Hepatitis Clinical Trials

Showing 1681-1700 of 1,819 trials

Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus

NCT00971308

The purpose of this study is to determine the antiviral effect following three days of dosing with BMS-824393 in chronically genotype subtype 1a and 1b Hepatitis C virus (HCV) infected subjects.

Chronic Hepatitis C

Bristol-Myers Squibb37 participantsStarted Oct 2009

Anaheim, California, United States • Cypress, California, United States • Miami, Florida, United States +3 more locations

UNKNOWN

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

NCT01273142

The purpose of this study is to demonstrate the difference in frequency and level of liver function disturbance between patients on efavirenz based ART, and patients on nevirapine based ART in HBV and HCV co-infected patients, (and/or with patients with abnormal liver function prior to ART), in China. Liver function tests will be measured at baseline and follow-up.

HIV InfectionsLiver ToxicityHepatitis Co-infection

Henan Provincial People's Hospital100 participantsStarted Jan 2011

COMPLETEDPhase 1

Drug-Drug Interaction Study in Healthy Subjects

NCT00904059

The purpose of this study is to assess the pharmacokinetics and safety of BMS-790052 and BMS-650032 when co-administered and when administered alone

Hepatitis C

Bristol-Myers Squibb28 participantsStarted May 2009

Austin, Texas, United States

Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

Drug-Drug Interaction Study in Healthy Subjects

Related Searches

Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects

Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy

Sonazoid Enhanced Liver Cancer Trial for Early Detection

VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer

VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram

Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients

Trial of Pegasys® in Patients With Chronic Hepatitis C

The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy

Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine

Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders

A Study of Single Dose of ABT-333 in Healthy Male Adults

A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults

A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults

Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet

Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis

Study of CTS-1027 in Hepatitis C Patients